This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results